Abstract
Knowledge of the actual active substances that act to initiate or modulate carcinogenests in humans is limited. The past two decades have been dedicated to the discovery of environmental factors including constituents of our diet that may be carcinogenic or modulators of carcinogenic process. Recent emphasis has been on the identification of cancer preventive agents. In this regard, animal models have been most useful. They are intensively used in the identification of the initiators and modulators of carcinogenesis as well as in the elucidation of the mechanism(s) of their action.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Kohlmeir L., Simonsen N., and Mottus K. (1995) Dietary modifiers of carcinogenesis. Environ. Health Persp. 103, 177–184.
Harris C. C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Rex 51, 5023s–5044s.
Farber E. and Rubin H. (1991) Cellular adaptation in the origin and development of cancer. Cancer Res. 51, 275l–2761
Bird R. P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93, 55–71.
Pereira M. A., Barnes L. H., Rassman V. L., Kelloff G. V., and Steele V. E. (1994). Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15, 1049–1054.
Wargovich M. J., Chen C., Jimenez A., Steele V. E, Velasco M, Stephens L. C, Price R., Gay K., and Kelloff G J. (1996) Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epldemiol Biomarkers Prev 5, 355–360
Thorup I, Mayer O., and Kristiansen E. (1994) Influence of a dietary fiber on development of dimethylhydrazine-incluced aberrant crypt foci and colon tumour incidence in Wistar rats. Nutr Cancer 21, 177–182
Carter J W., Lancaster H. K, Hardman W E., and Cameron I L (1994) Distribution of intestine associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine treated mice. Cancer Res 54, 4304–4307
Lasko C M and Bird R P (1995) Modulation of aberrant crypt foci by dietary fat and caloric restriction the effects of delayed intervention. Cancer Epidemiol Biomarkers Prev 4, 49–55.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Bird, R.P. (1998). Aberrant Crypt Foci System to Study Cancer Preventive Agents in the Colon. In: Hanausek, M., Walaszek, Z. (eds) Tumor Marker Protocols. Methods in Molecular Medicine™, vol 14. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-380-5:465
Download citation
DOI: https://doi.org/10.1385/0-89603-380-5:465
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-380-1
Online ISBN: 978-1-59259-598-3
eBook Packages: Springer Protocols